PURPOSE. This study was designed to determine whether the ability to adversely affect corneal epithelial cell health is a factor common to Pseudomonas aeruginosa keratitis strains and to assess the prevalence of each pathogenic phenotype and genotype in a canine model of naturally-acquired P. aeruginosa ocular infection. METHODS. P. aeruginosa ocular isolates were collected by sampling 100 dogs without disease (six isolates collected) and by sampling dogs with conjunctivitis (two isolates), endophthalmitis (one isolate), active keratitis (12 isolates), and resolved P. aeruginosa keratitis (four isolates). Phenotype was determined in vitro by quantifying corneal epithelial cell invasion by gentamicin survival assays, and cytotoxic activity by Trypan blue exclusion assays. Genotyping was performed for genes encoding the type III secreted effectors.
T he Gram-negative bacillus Pseudomonas aeruginosa is a frequent cause of opportunistic ocular infection. 1 P. aeruginosa has evolved a multitude of diverse virulence mechanisms and factors that permit efficient colonization of compromised ocular tissues and subsequent destructive disease. [2] [3] [4] [5] A diverse array of ocular and adnexal lesions are attributable to P. aeruginosa infection, including blepharitis, conjunctivitis, dacryocystitis, keratitis, scleritis, chorioretinitis, endophthalmitis, and orbital cellulitis. 6 -10 Ulcerative keratitis associated with P. aeruginosa infection is characterized by extensive dissolution of the corneal stroma and rapid progression of clinical signs. 11, 12 Historically, P. aeruginosa has been regarded as an extracellular pathogen. More recently, however, it was reported that some strains of P. aeruginosa are capable of invading and residing within corneal epithelial cells. 13 Intracellular multiplication assays confirm that bacteria remain viable and multiply within the invaded epithelial cells. 14 Other studies reported that P. aeruginosa is capable of toxin-mediated killing of epithelial cells. 15 When strains of P. aeruginosa that induced acute cytotoxicity were compared with strains that invade epithelial cells, a significant inverse correlation was found between these two properties. 16 This demonstrated that there are two distinct phenotypes of P. aeruginosa corneal isolates, one that is acutely cytotoxic and one that can enter corneal epithelial cells and survive intracellularly without killing the host cell. Experimental infection of mouse corneas with P. aeruginosa isolates of known pathogenic phenotype produced distinct corneal pathologies. 17 Infection with both cytotoxic and invasive strains produced severe keratitis; however, the predominant pathologic response with cytotoxic strains was corneal edema and the predominant response with invasive strains was corneal ulceration. A strain that was neither cytotoxic nor invasive produced minimal keratitis.
The invasive and cytotoxic phenotypes of P. aeruginosa correspond to distinct genotypes. 18 The molecular basis of these phenotypic properties is bacterial effector proteins secreted into host cell cytoplasm by a type III secretion system and controlled by the transcriptional activator ExsA. 19 Currently, four bacterial effector proteins have been identified: ExoS, ExoU, ExoT, and ExoY. Among human corneal isolates, both phenotypes have been associated with a classic genotype. P. aeruginosa invasive stains typically possess genes encoding for ExoS, ExoT, and ExoY, but lack the gene for ExoU. 18 Cytotoxic strains typically possess genes for ExoU, ExoT, and ExoY, but lack the gene for ExoS. 18 The effectors ExoS, ExoY, and ExoT inhibit invasion and ExoU confers cytotoxicity; therefore, the invasive phenotype is considered the default if bacterial effectors are not present. 20 -23 The purpose of this study was to determine whether the ability to adversely affect corneal epithelial cell health was a factor common to P. aeruginosa ulcerative keratitis strains and to characterize the relationship between P. aeruginosa pathogenic phenotype and ocular disease in a canine model of naturally-acquired P. aeruginosa ocular infection. A specific objective of this study was to determine whether the same two broad classes of P. aeruginosa genotypes are associated with ocular infection in dogs, as has been demonstrated for humans. Exploring the similarities and differences between results of studies examining different P. aeruginosa strain types in spon-taneous human infection, induced animal models of infection, and spontaneous animal infection models increases our knowledge of the validity of experimental animal models of ocular infection and their role in P. aeruginosa ocular disease research.
MATERIALS AND METHODS

Animals and Microbiologic Sample Collection
All protocols were approved by the Animal Care and Use Committee of Cornell University and were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Conjunctival swabs were collected from 200 canine eyes (100 dogs) meeting the following inclusion criteria: no clinical or historical evidence of external ocular disease, no history of receiving systemic antimicrobials in the preceding 30 days, and no history of receiving topical ophthalmic medications in the preceding 30 days. Samples were collected from dogs representing 27 separate canine breeds. Slit lamp biomicroscopic examination (Kowa SL-14; Kowa Co., Tokyo, Japan) was performed for each eye before sample collection. Samples were collected before the instillation of any ophthalmic solutions. A separate rayon-tipped swab and culture transport system (BBL CultureSwab Plus; Becton Dickinson, Sparks, MD) was used for each eye. The swab was gently brushed against the dorsal and ventral conjunctival fornices, avoiding contact with eyelid skin and cilia.
All dogs meeting inclusion criteria presented to the Cornell University Hospital for Animals during the 24-month study period, with naturally-acquired intra-or extraocular infection in which P. aeruginosa was isolated from ocular samples, were included in the study. Inclusion criteria for dogs with ocular infection included no history of receiving systemic or topical ophthalmic antimicrobials in the preceding 30 days. Samples were collected from dogs with ulcerative keratitis, conjunctivitis, and endophthalmitis by corneal scraping, conjunctival swab, or vitreous aspirate, respectively. Conjunctival swabs were also collected, as described for dogs without external ocular disease, from culture-confirmed P. aeruginosa ulcerative keratitis eyes 2 to 3 months after corneal ulcer resolution and the discontinuation of ophthalmic antimicrobials. Dogs examined at the Cornell University Hospital for Animals included both primary and referred cases; however, most ocular infections were either presented primarily or referred before medical intervention.
Clinical Data Collection
Signalment information, determined by physical examination and client supplied information, was recorded for each dog included in the infection group of the study. Complete ocular examination, including slit lamp biomicroscopy, indirect ophthalmoscopy (Heine EN20-01 indirect ophthalmoscope; Heine Optotechnik, Herrsching, Germany), fluorescein staining (Fluor-I-Strips; Schering-Plough Animal Health Co., Union, NJ), and Schirmer I tear testing (Schirmer tear test strips; Schering-Plough Animal Health Co.) were performed on each dog with ocular disease. For eyes with ulcerative keratitis, a corneal ulcer scoring system was used to quantify biomicroscopy findings. The following variables were scored for each eye: corneal ulcer area (defined as area of fluorescein retention relative to total corneal area): 0 ϭ Ͻ25%, 1 ϭ 26% to 50%, 2 ϭ 51% to 75%, 3 ϭ Ͼ76%; corneal ulcer depth (defined as deepest point of the ulceration relative to total corneal depth): 0 ϭ Ͻ25%, 1 ϭ 26% to 50%, 2 ϭ 51% to 75%, 3 ϭ Ͼ76%; anterior chamber reaction: 0 ϭ none, 1 ϭ mild aqueous flare, 2 ϭ moderate-to-marked aqueous flare, 3 ϭ hypopyon; corneal edema area relative to total corneal area: 0 ϭ Ͻ25%, 1 ϭ 26% to 50%, 2 ϭ 51% to 75%, 3 ϭ Ͼ76%; corneal leukocyte infiltration: 0 ϭ none, 1 ϭ mild, 2 ϭ moderate, 3 ϭ severe; and keratomalacia: 0 ϭ none, 1 ϭ mild, 2 ϭ moderate, 3 ϭ severe.
Bacteria Identification
Direct cultures on solid media (trypticase soy agar with 5% sheep blood, chocolate agar, Levine eosin methylene blue agar, and Columbia colistin-nalidixic acid agar) and an enrichment broth (brain heart infusion broth) were performed for each sample. Direct cultures and enrichment subcultures were incubated at 37°C in 6% CO 2 and read at 24 and 48 hours. All microorganism identification and antimicrobial susceptibility determinations were performed with an automated system (Sensititre; Trek Diagnostic Systemic Inc, Cleveland, OH).
Preparation of Bacteria
Bacteria were grown on trypticase soy agar plates overnight at 37°C. Immediately before infection, bacteria were suspended in minimal essential Eagle medium (50% [vol/vol]) in Hams F-12 (BioWhittaker, Walkersville, MD) tissue culture medium (EMEM/Hams F-12) to a final approximate concentration of 5 ϫ 10 6 CFU/mL. P. aeruginosa clinical isolates 6294 and 6206 were used as positive controls for invasion and cytotoxicity assays, respectively.
Invasion and Cytotoxicity Assays
Rabbit corneal epithelial cells (RCEs) were grown in SHEM medium as previously described 16 and seeded onto 96-well flat-bottom microtiter plates until cells reached 50% to 75% confluency. At the time of infection, RCEs were washed with pre-warmed phosphate-buffered saline (PBS) and 100 L of pre-warmed diluted bacteria was added to each well in triplicates. EMEM/Hams F-12 medium was used as a negative control. Bacterial exposure continued for 3 hours at 37°C, 5.0% CO 2 . RCEs were washed with pre-warmed PBS and then treated with 100 L of gentamicin (0.4% [vol/vol]; 200 g/mL; BioWhittaker) in EMEM/Hams F-12 medium for 1 hour. After another PBS wash, 100 L of Trypan blue (10% [vol/vol]) in Hams F-12 was added to the cells and incubation continued for 15 minutes. Trypan blue was removed and 100 L of pre-warmed Hams F-12 medium was added to each well. Brightfield and phase contrast images were taken on an inverted microscope (Olympus IX-70; Olympus America Inc., Center Valley, PA) attached to a video camera (Optronics, Goleta, CA) at ϫ200 magnification.
To assay for bacterial invasion, the RCEs were lysed in Triton X-100 (0.25% [vol/vol]; LabChem Inc., Pittsburgh, PA) in PBS for 15 minutes. The cells were scraped vigorously to ensure complete lysis. Undiluted and 10
Ϫ1 dilutions of the lysates were plated in duplicates onto MacConkey agar plates and incubated for 14 to 16 hours at 37°C. Isolates were considered cytotoxic if they exhibited Trypan blue staining with low invasion numbers, invasive if they if exhibited low or no Trypan blue staining and high invasion numbers, and neither phenotype if they exhibited low or no Trypan blue staining and low invasion numbers.
Genotyping of P. aeruginosa
Genotyping of bacterial isolates was performed by the polymerase chain reaction (PCR) on target loci for exotoxins of the type III secretory system in P. aeruginosa. The following primers were used to amplify P. aeruginosa exotoxins: ExoS (sense, 5Ј-TCA GGT ACC CGG CAT TCA CTA CGC GG-3Ј; antisense, 5Ј-TCA CTG CAG GTT CGT GAC GTC TTT CT-3Ј), ExoT (sense, 5Ј-AAT CGC CGT CCA ACT GCA TGC G-3Ј; antisense, 5Ј-TGT TCG CCG AGG TAC TGC TC-3Ј), ExoU (sense, 5Ј-AGC GTT AGT GAC GTG CG-3Ј; antisense, 5Ј-GCG CAT GGC ATC GAG TAA CTG-3Ј), ExoY (sense, 5Ј-TCC AAG CTT ATG CGT ATC GAC GGT CA-3Ј; antisense, 5Ј-CGT ATC GAT CCG AGG GGG GTG TAT CT-3Ј). All PCR reactions were performed in 50 L volumes containing 0.2 M of each primer pair in 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl 2 , 200 M of each dNTP, 0.1% TritonX-100, 0.5 U Taq Polymerase (Promega, Madison, WI) and with approximately 10 5 bacteria. All reactions except for ExoU were performed at 1 cycle at 94°C for 5 minutes, 30 cycles at 94°C for 1 minute, 58°C for 1 minute, 72°C for 1 minute, and 1 cycle at 72°C for 5 minutes. ExoU reactions were performed at an annealing temperature of 55°C. All amplified targets were resolved on 1.2% agarose at 10 V/cm for 30 minutes to give product sizes of 565bp (ExoS), 956bp (ExoT), 1572bp (ExoU), and 749bp (ExoY). 
RESULTS
P. aeruginosa was isolated from conjunctival samples of six eyes (3.0%) sampled without clinical evidence of ocular disease. P. aeruginosa was isolated from 15 dogs with ocular infections, including 12 eyes with ulcerative keratitis, two eyes with bacterial conjunctivitis associated with keratoconjunctivitis sicca, and one eye with exogenous infectious endophthalmitis resulting from penetrating ocular trauma. Eight of the dogs with P. aeruginosa ulcerative keratitis were available for repeat sampling 2 to 3 months post-resolution of the corneal lesion and P. aeruginosa was again isolated from four of these eyes. These P. aeruginosa isolates differed by two to six in vitro antimicrobial susceptibilities from their respective initial isolate, but all were susceptible to the antimicrobial used during treatment of the original infection. All dogs with ulcerative keratitis were successfully treated (i.e., globe and vision preservation) with topical ciprofloxacin 0.3% ophthalmic solution administered with (n ϭ 6) or without (n ϭ 6) additional surgical procedures (e.g., lamellar keratoplasty, corneoconjunctival transposition, or conjunctival pedicle graft). Selected in vitro antimicrobial susceptibility determinations for all 25 isolates are listed in Table 1 . P. aeruginosa isolates from the conjunctival flora of dogs without clinical extraocular disease were phenotypically invasive (n ϭ 5) and cytotoxic (n ϭ 1; Table 2 ). Isolates from dogs with ocular infections were phenotypically invasive (n ϭ 12), cytotoxic (n ϭ 2), or displayed neither invasiveness nor cytotoxicity (n ϭ 1). The ratio of the prevalence of invasive to cytoxic strains with 95% confidence intervals (CI) was 0.83 (CI, 0.42-0.99) for normal conjunctival flora isolates and 0.80 (CI, 0.54 -0.94) for ocular infection isolates. There was no significant difference in the distribution of each phenotype between dogs with or without ocular infections. All P. aeruginosa isolates from the conjunctival flora of dogs post-resolution of ulcerative keratitis were invasive (n ϭ 4), but only two of these isolates shared the same phenotype and genotype as the original isolate.
The genotype of 21 isolates was congruent with the classic genotype-phenotype pattern reported for human corneal isolates (Table 2) . Discordance between phenotype and the classic genotype was identified in four isolates, including one normal conjunctival microflora strain, one conjunctivitis strain, and two ulcerative keratitis strains. The conjunctival microflora strain was phenotypically cytotoxic, but the genotype was unusual as it encoded all four known effectors. The conjunctivitis strain displayed neither phenotype, but a classic invasive genotype. The ulcerative keratitis strains were both phenotypically invasive, but unusual because one had a cytotoxic genotype without ExoY and one encoded none of the type III secretion effectors.
Microscopically visible adverse effects on corneal epithelial cell health (e.g., cell rounding, sloughing from plates, loss) were observed significantly (P Յ 0.03) more frequently for keratitis strains (6/12) than other strains (1/13; Fig. 1 ). Of the six keratitis strains adversely affecting cell health, three were invasive, two were cytotoxic, and one was neither genotype (lacked all four known effectors). The one non-keratitis strain affecting cell health was cytotoxic, but unusual in that it encoded all four known effectors. Therefore, only keratitis strains had visible adverse effects on live host cells in the absence of overt cytotoxicity (4/12 keratitis strains vs. 0/13 non-keratitis strains).
Other notable findings included that all normal conjunctival microflora strains encoded ExoS, including an ExoU ϩ strain that was phenotypically cytotoxic. Of the keratitis strains negatively impacting cell health, two strains did not encode ExoU and were both phenotypically and genotypically invasive. The three strains with atypical genotypes had visible adverse effects on corneal epithelial cell health. All strains isolated from ocular infections had at least one of the following effects on corneal epithelial cells: invasion, cytotoxicity, or the induction of abnormal morphology.
The clinical appearance of corneal lesions in dogs with ulcerative keratitis was highly variable; however, all corneal ulcerations were unilateral, severe, and rapidly progressive (Fig. 2) . In all dogs sampled, clinical findings were typical for canine P. aeruginosa ulcerative keratitis. 12 No significant differences were found between dogs infected with each phenotype and the clinical biomicroscopic corneal ulcer scoring system characteristics evaluated (data not shown). Dogs with ocular infections included nine brachycephalic and six mesaticephalic/dolichocephalic skull types. Breeds represented included Shih Tzu (n ϭ 5 dogs), Pekingese (n ϭ 3), Jack Russell Terrier (n ϭ 2), mixed breed (n ϭ 2), Pug (n ϭ 1), American Cocker Spaniel (n ϭ 1), and Miniature Schnauzer (n ϭ 1). There were four spayed females, seven intact females, two castrated males, and two intact males. There were no significant differences for sex and skull type between dogs with invasive and cytotoxic isolates. Preexisting ocular disease identified during ophthalmological examination in dogs with ulcerative keratitis included keratoconjunctivitis sicca (n ϭ 4 dogs), medial canthal trichiasis (n ϭ 2), facial nerve paralysis (n ϭ 1), and pigmentary keratitis (n ϭ1).
For dogs with all types of ocular infections, the median age was 65 months (range: 14 to 180) in dogs with the invasive phenotype and the median age was 7 months (all dogs 7 months old) in dogs with the cytotoxic phenotype. This difference in dog ages between the invasive and cytotoxic phenotype groups for dogs with all types of ocular infections was statistically significant (P Յ 0.02). For dogs with ulcerative keratitis specifically, the median age for dogs with the invasive phenotype was 61.5 months (range, 1-180) and the median age was 7 months (all dogs 7 months old) for dogs with the cytotoxic phenotype. This difference in dog ages between the invasive and cytotoxic phenotype ulcerative keratitis groups was statistically significant (P Յ 0.03).
DISCUSSION
In contrast to other animal models requiring experimental infection induction, 24 -26 the dogs of this report are a naturallyoccurring P. aeruginosa ulcerative keratitis model. This largeanimal model of infection, occurring without experimental corneal wounding or bacterial inoculation, may more closely replicate conditions in natural human P. aeruginosa ulcerative keratitis. P. aeruginosa corneal infections occur spontaneously, subsequent to compromise of anatomic or immunologic corneal protective barriers, with a high frequency in dogs and produce clinical lesions similar to those observed in humans. [27] [28] [29] The invasive phenotype of P. aeruginosa predominated in the dogs of this study, accounting for 80% of isolates from dogs 14 Invasive strains of P. aeruginosa may also directly kill epithelial cells after prolonged incubation in a bacterial density-dependent manner. 30 Aminoglycosides, and other poorly cell-permeable antimicrobials, may be suboptimal therapeutics against invasive strains of P. aeruginosa. [31] [32] [33] A murine model of P. aeruginosa keratitis has confirmed tobramycin, a non cell-permeable antibiotic, is less effective at eradicating bacteria from corneas infected with invasive strains than ofloxacin, a cell-permeable antibiotic. 34 Furthermore, that study demonstrated several aminoglycosides and fluoroquinolones were capable of killing cytotoxic and invasive strains when not cell-associated, but only cell-permeable fluoroquinolones killed invasive strains within corneal epithelial cells.
Invasive and cytotoxic P. aeruginosa strains were isolated in approximately equal proportion from human clinical cases of ulcerative keratitis. 35 A significant relationship was present between P. aeruginosa phenotype and patient age, with cytotoxic strains associated with patients Ͻ50 years of age and invasive strains associated with patients Ͼ50 years of age. These age-associated changes in immunity are similar between dogs and humans. 39, 40 Age-related changes of polymorphonuclear cell function impair P. aeruginosa phagocytosis, delay corneal clearance, and increase corneal bacterial loads. [41] [42] [43] The prevalence of P. aeruginosa isolation from dogs without clinically apparent extraocular disease in this study was comparable to previous reports in which P. aeruginosa was a consistent, but relatively infrequent, inhabitant of the canine extraocular microflora and was isolated from 1% to 14% of eyes. 44 -50 The relative importance of conjunctival versus environmental sources of P. aeruginosa during initiation of canine ocular infections is unknown, but the similar prevalence of invasive and cytotoxic strains among extraocular microflora and infection isolates suggests that the conjunctival flora may be an important bacterial reservoir and both phenotypes are capable of inducing opportunistic ocular infection during appropriate circumstances. The consistent presence of P. aeruginosa in the normal conjunctival microflora of dogs contrasts with humans where P. aeruginosa is most often reported to be a rare and sporadic isolate in the absence of predisposing extraocular disease. [51] [52] [53] It is partially on the basis of these reports that, in humans, P. aeruginosa ocular infections are frequently believed to originate from environmental bacterial sources. 54 -56 In disagreement with most studies of the human extraocular microflora; however, sporadic large human conjunctival microflora surveys have isolated P. aeruginosa from 5.8% to 6.7% of eyes; a prevalence similar to that reported for dogs. 57, 58 Among individuals or populations where P. aeruginosa is present in the extraocular microflora, the importance of this endogenous source of bacteria in the pathogenesis of ocular infections and the predisposition toward infection resultant from its presence is currently unknown.
P. aeruginosa was isolated from the conjunctival flora of 50% of dogs sampled post-resolution of ulcerative keratitis. This frequency is notably higher than the 3% prevalence of P. aeruginosa within the conjunctival flora of dogs without ocular disease. All isolates collected from dogs after keratitis resolution had different in vitro antimicrobial susceptibility profiles, and only 50% shared the same phenotype and genotype as the original corneal isolate. It is unknown whether P. aeruginosa was present in the conjunctival flora before development of ulcerative keratitis; however, these results suggest that some dogs may be prone to the chronic presence of P. aeruginosa in the extraocular microflora. It does not appear that the same bacterial strain is responsible for this presence, but that bacterial mutation or, more likely, conjunctival recolonization from environmental sources or other endogenous flora is occurring. The reasons for this recolonization are currently unclear, but could include a variety of bacterial, environmental, or host factors.
Discordance between phenotype and the classic genotype was identified in four canine isolates. This may have resulted from production of effectors that were not secreted into host cells or activity of unidentified effectors modulating invasion and cytotoxicity. Only ulcerative keratitis strains had visible adverse effects on corneal epithelial cell health in the absence of overt cytotoxicity, suggesting that virulence strategies that affect live epithelial cells are selected for among ulcerative keratitis strains. The results of this study further suggest P. aeruginosa possesses virulence factors, other than invasiveness and cytotoxicity, which impact cell health. These virulence factors were not identified in the present study, but may include one or more specific proteases or exoenzymes. Study of the canine model of spontaneous P. aeruginosa ocular infection has the potential to advance the understanding of both human and animal infection pathogenesis, improve therapeutic and management approaches for human infection, and contribute to the development of animal models that more closely resemble spontaneous human infection.
